Synapse - Larry Norton

Results (36)

Early circulating tumor DNA shedding kinetics for prediction of platinum sensitivity in patients with small cell lung cancer

Journal Article

Murciano-Goroff, Y. R.; Hui, A. B. Y.; Araujo Filho, J. A.; Hamilton, E. G.; Chabon, J. J.; Moding, E. J.; Bonilla, R. F.; Lebow, E. S.; Gomez, D.; Rimner, A.; more...
JCO Precision Oncology (2024)

Fulltext@MSK | Save

Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer

Meeting Abstract

Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
Cancer Research (2022)

Fulltext@MSK | Save

The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: A simulation-based analysis

Journal Article

Ward, Z. J.; Atun, R.; Hricak, H.; Asante, K.; McGinty, G.; Sutton, E. J.; Norton, L.; Scott, A. M.; Shulman, L. N.
Lancet Oncology (2021)

Fulltext@MSK | Save

Accuracy of magnetic resonance imaging-guided biopsy to verify breast cancer pathologic complete response after neoadjuvant chemotherapy: A nonrandomized controlled trial

Journal Article

Sutton, E. J.; Braunstein, L. Z.; El-Tamer, M. B.; Brogi, E.; Hughes, M.; Bryce, Y.; Gluskin, J. S.; Powell, S.; Woosley, A.; Tadros, A.; more...
JAMA Network Open (2021)

Fulltext@MSK | Save

Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

Journal Article

Razavi, P.; Dickler, M. N.; Shah, P. D.; Toy, W.; Brown, D. N.; Won, H. H.; Li, B. T.; Shen, R.; Vasan, N.; Modi, S.; more...
Nature Cancer (2020)

Fulltext@MSK | Save

Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)

Meeting Abstract

Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
Cancer Research (2019)

Fulltext@MSK | Save

Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Phase I trial: PI3Kα inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR+) metastatic breast cancer (MBC)

Meeting Abstract

Shah, P. D.; Moynahan, M. E.; Modi, S.; Caravella, B. A.; Datko, F. M.; Zamora, S.; Comen, E.; Gilewski, T.; Sugarman, S. M.; D'Andrea, G.; more...
Cancer Research (2015)

Fulltext@MSK | Save

Advances in managing breast cancer: A clinical update

Journal Article

Gucalp, A.; Gupta, G. P.; Pilewskie, M. L.; Sutton, E. J.; Norton, L.
F1000Prime Reports (2014)

Fulltext@MSK | Save

Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer

Journal Article

Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
Clinical Breast Cancer (2013)

Fulltext@MSK | Save